{"id":14444,"date":"2012-01-13T10:35:00","date_gmt":"2012-01-13T09:35:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/novartis-annuncia-taglio-posti-lavoro-negli-states\/"},"modified":"2012-01-13T10:35:00","modified_gmt":"2012-01-13T09:35:00","slug":"novartis-annuncia-taglio-posti-lavoro-negli-states","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/novartis-annuncia-taglio-posti-lavoro-negli-states\/","title":{"rendered":"Novartis announces job cuts in the States"},"content":{"rendered":"<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\"><font face=\"Calibri\">Dark times ahead for Novartis in the United States.<\/p>\n<p><\/font><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\"><font face=\"Calibri\"><span style=\"mso-spacerun: yes\">&nbsp;<\/span>The Swiss pharmaceutical giant will in fact have to cut 1,960 jobs in its US division due to a series of adverse factors. <\/p>\n<p><\/font><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\"><font face=\"Calibri\">Among these, the loss of the Diovan patent, the flop of Rasilez, a drug for controlling high blood pressure that failed to become a blockbuster as hoped, and the halt of research on two experimental drugs, which will cost the company about 160 Millions of dollars.<\/p>\n<p><\/font><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\"><font face=\"Calibri\"><span style=\"mso-spacerun: yes\">&nbsp;<\/span>The restructuring, which is expected to deliver annual savings of approximately $450 million by 2013, will impact the company&#039;s bottom line over the next six months.<\/p>\n<p><\/font><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\"><font face=\"Calibri\"><span style=\"mso-spacerun: yes\">&nbsp;<\/span>Novartis is not the only multinational pharmaceutical company experiencing crisis moments: in fact, there are many companies suffering from increasingly fierce competition from generic drugs, as the patents of the best-selling drugs gradually expire.<\/p>\n<p><\/font><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><span style=\"line-height: 115%; font-family: &quot;Verdana&quot;,&quot;sans-serif&quot;; color: #7a7a7a; font-size: 10pt\">January 13, 2012&nbsp;&nbsp; <img","protected":false},"excerpt":{"rendered":"<p>Si prospettano tempi bui negli Stati Uniti per Novartis. &nbsp;Il colosso farmaceutico elvetico dovr&agrave; infatti tagliare 1.960 posti di lavoro nella propria divisione USA a causa di una serie di fattori avversi. Tra questi, la perdita del brevetto del Diovan, il flop del Rasilez, farmaco per il controllo della pressione alta che non &egrave; riuscito &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14444","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14444"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14444\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}